PLPL
Plandai Biotechnology, Inc.
Key Financials
Operating Income
$-8849567
↓ 11.3%
Gross Profit
$-425195
↑ 29.6%
Revenue
$92898
↓ 65.0%
Net Income
$-10072344
↑ 35.2%
Total Assets
$8.5M
↓ 12.2%
Shareholders' Equity
$-6499090.00
↓ 195.1%
Cash & Equivalents
$33619.00
↓ 78.5%
Total Liabilities
$16.8M
↑ 27.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 3/20/2023 | View on SEC |
| 10-K | 3/16/2023 | View on SEC |
| SC 13G/A | 2/15/2022 | View on SEC |
| SC 13G/A | 1/27/2021 | View on SEC |
| SC 13G | 1/21/2021 | View on SEC |
| SC 13G/A | 2/13/2020 | View on SEC |
| SC 13G/A | 2/15/2019 | View on SEC |
| SC 13G | 2/14/2018 | View on SEC |
| SC 13G/A | 4/24/2017 | View on SEC |
| SC 13G/A | 2/1/2017 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PLPL |
| Company Name | Plandai Biotechnology, Inc. |
| CIK | 1317880 |
| Sector | Pharmaceutical Preparations |
| Industry | Smaller reporting company |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| Phone | (619) 239-9034 |